S'abonner

First report on chromosomal abnormalities in Eastern Morocco: Identification of a new case of a de novo partial trisomy 13q using single-nucleotide polymorphism array - 07/02/24

Doi : 10.1016/j.arcped.2023.10.002 
Manal Elidrissi Errahhali a, b, 1, Mounia Elidrissi Errahhali a, b, 1, Sara Ramdani a, Saida Lhousni a, b, Noufissa Benajiba c, Maria Rkain c, Abdeladim Babakhouya c, Aziza Elouali c, Ayad Ghanam c, Rim Amrani d, Sahar Messaoudi d, Anass Ayyad d, Bouchra Oneib e, Ahmed Mimouni f, Hanane Saadi f, Sanae Allaoui g, Meryem Ouarzane a, b, Agnès Guichet h, Majida Charif a, b, i, Redouane Boulouiz a, b, Mohammed Bellaoui a, b,
a Genetics Unit, Medical Sciences Research Laboratory, Faculty of Medicine and Pharmacy, University Mohammed Premier, Oujda, Morocco 
b BRO Biobank, Faculty of Medicine and Pharmacy, University Mohammed Premier, Oujda, Morocco 
c Department of Pediatrics, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, University Mohammed Premier, Oujda, Morocco 
d Department of Neonatology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, University Mohammed Premier, Oujda, Morocco 
e Department of Psychiatry, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, University Mohammed Premier, Oujda, Morocco 
f Department of Gynecology and Obstetrics, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, University Mohammed Premier, Oujda, Morocco 
g Department of Pediatrics, El Farabi Hospital, Oujda, Morocco 
h Departments of Genetics, University Hospital Angers, 49933 Angers, France 
i Genetic and Immuno-Cell Therapy Team, Mohammed First University, Oujda 60000, Morocco 

Corresponding author at: Genetics Unit, Medical Sciences Research Laboratory, Faculty of Medicine and Pharmacy, University Mohammed Premier, Oujda, Morocco.Genetics Unit, Medical Sciences Research Laboratory, Faculty of Medicine and PharmacyUniversity Mohammed PremierOujdaMorocco

Abstract

Background

Chromosomal abnormalities are the main cause of birth defects, intellectual disability, and miscarriages. They contribute to significant human morbidity and infant mortality. Here we report for the first time the chromosomal abnormalities encountered in the population of Eastern Morocco. Furthermore, we describe a new case of a de novo partial trisomy 13q combined with a terminal deletion in an 11-day-old girl.

Methods

From November 2015 to March 2022, 195 patients from the BRO Biobank who were clinically suspected of having chromosomal abnormalities were referred to the cytogenetics laboratory of the Genetics Unit of the Faculty of Medicine and Pharmacy of Oujda for cytogenetic study. Karyotyping analysis was performed on peripheral blood samples using standard R banding techniques. To identify single-nucleotide polymorphism (SNP) and copy number variants (CNVs), Illumina SNP array was used.

Results

Among 195 studied cases, 32 (16.4 %) had abnormal karyotypes, of which 12 cases had numerical aberrations while 20 cases had structural aberrations. The most common numerical aberrations were Turner syndrome and Down syndrome followed by Edward, Patau, and Klinefelter syndromes. For structural aberrations, translocations were the most common, followed by derivative chromosomes, inversions, deletions, and an addition on chromosome 13 identified in an 11-day-old girl. To further characterize this addition, SNP array was carried out and revealed a 58.8-Mb duplication in region 13q14.3q34 associated with a 1-Mb deletion in region 13q34. Follow-up parental chromosomes analysis showed normal karyotypes for the parents, confirming that this partial trisomy 13q was de novo. Comparison of the phenotype associated with this novel duplication on chromosome 13q with those previously reported confirmed the considerable variability in the phenotype of the patients with partial trisomy 13q.

Conclusion

This study provided the first report on chromosomal abnormalities in Eastern Morocco and it enriched the phenotype spectrum of partial trisomy 13q and further confirmed the genotype–phenotype correlations. Furthermore, these findings justify the need to set up microarray comparative genomic hybridization techniques in Morocco for better genetic diagnosis.

Le texte complet de cet article est disponible en PDF.

Keywords : BRO biobank, Chromosomal abnormalities, Partial trisomy 13, SNP array


Plan


© 2023  French Society of Pediatrics. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 31 - N° 2

P. 112-116 - février 2024 Retour au numéro
Article précédent Article précédent
  • Assessment of medication discrepancy, medication appropriateness, and cost analysis among patients with pediatric nephrotic syndrome: An ambispective cohort observational study
  • Deepthi Avvaru, M Santhosh Reddy, Shinaj Azar MS, Shashikala Wali, Mahantesh V Patil, Ramesh Bhandari, M S Ganachari
| Article suivant Article suivant
  • Effect of nusinersen after 3 years of treatment in 57 young children with SMA in terms of SMN2 copy number or type
  • Frédérique Audic, Sonia M. Dubois, Julien Durigneux, Christine Barnerias, Arnaud Isapof, Marie-Christine Nougues, Jean-Baptiste Davion, Christian Richelme, Carole Vuillerot, Laure Legoff, Pascal Sabouraud, Claude Cances, Vincent Laugel, Juliette Ropars, Caroline Espil-Taris, Valérie Trommsdorff, Anne Pervillé, Marta Gomez Garcia-de-la-Banda, Hervé Testard, Mondher Chouchane, Ulrike Walther-Louvier, Cyril Schweizer, Cécile Halbert, Myriam Badri, Susana Quijano-Roy, Brigitte Chabrol, Isabelle Desguerre

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.